Mycobacterium Tuberculosis Market - Global Outlook and Forecast 2022-2028

March 2022 | 102 pages | ID: MD2B65F4D3F7EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Mycobacterium Tuberculosis in Global, including the following market information:

Global Mycobacterium Tuberculosis Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Mycobacterium Tuberculosis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Real-time Inspection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Mycobacterium Tuberculosis include Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Johnson & Johnson, Pfizer, Novartis, Abbott, AstraZeneca and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mycobacterium Tuberculosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Mycobacterium Tuberculosis Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Mycobacterium Tuberculosis Market Segment Percentages, by Type, 2021 (%)

• Real-time Inspection
• Nucleic Acid Amplification Test
• Skin Test for Tuberculosis
• Other

Global Mycobacterium Tuberculosis Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Mycobacterium Tuberculosis Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Specialist Clinic
• Diagnostic Laboratory

Global Mycobacterium Tuberculosis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Mycobacterium Tuberculosis Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Mycobacterium Tuberculosis revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Mycobacterium Tuberculosis revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Lupin
• Macleods Pharmaceuticals
• Otsuka Pharmaceutical
• Johnson & Johnson
• Pfizer
• Novartis
• Abbott
• AstraZeneca
• Bayer
• Merck
• Sanofi
• Thermo Fisher Scientific
• Danaher
• Roche
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Mycobacterium Tuberculosis Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Mycobacterium Tuberculosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MYCOBACTERIUM TUBERCULOSIS OVERALL MARKET SIZE

2.1 Global Mycobacterium Tuberculosis Market Size: 2021 VS 2028
2.2 Global Mycobacterium Tuberculosis Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Mycobacterium Tuberculosis Players in Global Market
3.2 Top Global Mycobacterium Tuberculosis Companies Ranked by Revenue
3.3 Global Mycobacterium Tuberculosis Revenue by Companies
3.4 Top 3 and Top 5 Mycobacterium Tuberculosis Companies in Global Market, by Revenue in 2021
3.5 Global Companies Mycobacterium Tuberculosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mycobacterium Tuberculosis Players in Global Market
  3.6.1 List of Global Tier 1 Mycobacterium Tuberculosis Companies
  3.6.2 List of Global Tier 2 and Tier 3 Mycobacterium Tuberculosis Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Mycobacterium Tuberculosis Market Size Markets, 2021 & 2028
  4.1.2 Real-time Inspection
  4.1.3 Nucleic Acid Amplification Test
  4.1.4 Skin Test for Tuberculosis
  4.1.5 Other
4.2 By Type - Global Mycobacterium Tuberculosis Revenue & Forecasts
  4.2.1 By Type - Global Mycobacterium Tuberculosis Revenue, 2017-2022
  4.2.2 By Type - Global Mycobacterium Tuberculosis Revenue, 2023-2028
  4.2.3 By Type - Global Mycobacterium Tuberculosis Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Mycobacterium Tuberculosis Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Specialist Clinic
  5.1.4 Diagnostic Laboratory
5.2 By Application - Global Mycobacterium Tuberculosis Revenue & Forecasts
  5.2.1 By Application - Global Mycobacterium Tuberculosis Revenue, 2017-2022
  5.2.2 By Application - Global Mycobacterium Tuberculosis Revenue, 2023-2028
  5.2.3 By Application - Global Mycobacterium Tuberculosis Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Mycobacterium Tuberculosis Market Size, 2021 & 2028
6.2 By Region - Global Mycobacterium Tuberculosis Revenue & Forecasts
  6.2.1 By Region - Global Mycobacterium Tuberculosis Revenue, 2017-2022
  6.2.2 By Region - Global Mycobacterium Tuberculosis Revenue, 2023-2028
  6.2.3 By Region - Global Mycobacterium Tuberculosis Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Mycobacterium Tuberculosis Revenue, 2017-2028
  6.3.2 US Mycobacterium Tuberculosis Market Size, 2017-2028
  6.3.3 Canada Mycobacterium Tuberculosis Market Size, 2017-2028
  6.3.4 Mexico Mycobacterium Tuberculosis Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Mycobacterium Tuberculosis Revenue, 2017-2028
  6.4.2 Germany Mycobacterium Tuberculosis Market Size, 2017-2028
  6.4.3 France Mycobacterium Tuberculosis Market Size, 2017-2028
  6.4.4 U.K. Mycobacterium Tuberculosis Market Size, 2017-2028
  6.4.5 Italy Mycobacterium Tuberculosis Market Size, 2017-2028
  6.4.6 Russia Mycobacterium Tuberculosis Market Size, 2017-2028
  6.4.7 Nordic Countries Mycobacterium Tuberculosis Market Size, 2017-2028
  6.4.8 Benelux Mycobacterium Tuberculosis Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Mycobacterium Tuberculosis Revenue, 2017-2028
  6.5.2 China Mycobacterium Tuberculosis Market Size, 2017-2028
  6.5.3 Japan Mycobacterium Tuberculosis Market Size, 2017-2028
  6.5.4 South Korea Mycobacterium Tuberculosis Market Size, 2017-2028
  6.5.5 Southeast Asia Mycobacterium Tuberculosis Market Size, 2017-2028
  6.5.6 India Mycobacterium Tuberculosis Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Mycobacterium Tuberculosis Revenue, 2017-2028
  6.6.2 Brazil Mycobacterium Tuberculosis Market Size, 2017-2028
  6.6.3 Argentina Mycobacterium Tuberculosis Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Mycobacterium Tuberculosis Revenue, 2017-2028
  6.7.2 Turkey Mycobacterium Tuberculosis Market Size, 2017-2028
  6.7.3 Israel Mycobacterium Tuberculosis Market Size, 2017-2028
  6.7.4 Saudi Arabia Mycobacterium Tuberculosis Market Size, 2017-2028
  6.7.5 UAE Mycobacterium Tuberculosis Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Lupin
  7.1.1 Lupin Corporate Summary
  7.1.2 Lupin Business Overview
  7.1.3 Lupin Mycobacterium Tuberculosis Major Product Offerings
  7.1.4 Lupin Mycobacterium Tuberculosis Revenue in Global Market (2017-2022)
  7.1.5 Lupin Key News
7.2 Macleods Pharmaceuticals
  7.2.1 Macleods Pharmaceuticals Corporate Summary
  7.2.2 Macleods Pharmaceuticals Business Overview
  7.2.3 Macleods Pharmaceuticals Mycobacterium Tuberculosis Major Product Offerings
  7.2.4 Macleods Pharmaceuticals Mycobacterium Tuberculosis Revenue in Global Market (2017-2022)
  7.2.5 Macleods Pharmaceuticals Key News
7.3 Otsuka Pharmaceutical
  7.3.1 Otsuka Pharmaceutical Corporate Summary
  7.3.2 Otsuka Pharmaceutical Business Overview
  7.3.3 Otsuka Pharmaceutical Mycobacterium Tuberculosis Major Product Offerings
  7.3.4 Otsuka Pharmaceutical Mycobacterium Tuberculosis Revenue in Global Market (2017-2022)
  7.3.5 Otsuka Pharmaceutical Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Mycobacterium Tuberculosis Major Product Offerings
  7.4.4 Johnson & Johnson Mycobacterium Tuberculosis Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Mycobacterium Tuberculosis Major Product Offerings
  7.5.4 Pfizer Mycobacterium Tuberculosis Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Mycobacterium Tuberculosis Major Product Offerings
  7.6.4 Novartis Mycobacterium Tuberculosis Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 Abbott
  7.7.1 Abbott Corporate Summary
  7.7.2 Abbott Business Overview
  7.7.3 Abbott Mycobacterium Tuberculosis Major Product Offerings
  7.7.4 Abbott Mycobacterium Tuberculosis Revenue in Global Market (2017-2022)
  7.7.5 Abbott Key News
7.8 AstraZeneca
  7.8.1 AstraZeneca Corporate Summary
  7.8.2 AstraZeneca Business Overview
  7.8.3 AstraZeneca Mycobacterium Tuberculosis Major Product Offerings
  7.8.4 AstraZeneca Mycobacterium Tuberculosis Revenue in Global Market (2017-2022)
  7.8.5 AstraZeneca Key News
7.9 Bayer
  7.9.1 Bayer Corporate Summary
  7.9.2 Bayer Business Overview
  7.9.3 Bayer Mycobacterium Tuberculosis Major Product Offerings
  7.9.4 Bayer Mycobacterium Tuberculosis Revenue in Global Market (2017-2022)
  7.9.5 Bayer Key News
7.10 Merck
  7.10.1 Merck Corporate Summary
  7.10.2 Merck Business Overview
  7.10.3 Merck Mycobacterium Tuberculosis Major Product Offerings
  7.10.4 Merck Mycobacterium Tuberculosis Revenue in Global Market (2017-2022)
  7.10.5 Merck Key News
7.11 Sanofi
  7.11.1 Sanofi Corporate Summary
  7.11.2 Sanofi Business Overview
  7.11.3 Sanofi Mycobacterium Tuberculosis Major Product Offerings
  7.11.4 Sanofi Mycobacterium Tuberculosis Revenue in Global Market (2017-2022)
  7.11.5 Sanofi Key News
7.12 Thermo Fisher Scientific
  7.12.1 Thermo Fisher Scientific Corporate Summary
  7.12.2 Thermo Fisher Scientific Business Overview
  7.12.3 Thermo Fisher Scientific Mycobacterium Tuberculosis Major Product Offerings
  7.12.4 Thermo Fisher Scientific Mycobacterium Tuberculosis Revenue in Global Market (2017-2022)
  7.12.5 Thermo Fisher Scientific Key News
7.13 Danaher
  7.13.1 Danaher Corporate Summary
  7.13.2 Danaher Business Overview
  7.13.3 Danaher Mycobacterium Tuberculosis Major Product Offerings
  7.13.4 Danaher Mycobacterium Tuberculosis Revenue in Global Market (2017-2022)
  7.13.5 Danaher Key News
7.14 Roche
  7.14.1 Roche Corporate Summary
  7.14.2 Roche Business Overview
  7.14.3 Roche Mycobacterium Tuberculosis Major Product Offerings
  7.14.4 Roche Mycobacterium Tuberculosis Revenue in Global Market (2017-2022)
  7.14.5 Roche Key News
7.15 Novartis
  7.15.1 Novartis Corporate Summary
  7.15.2 Novartis Business Overview
  7.15.3 Novartis Mycobacterium Tuberculosis Major Product Offerings
  7.15.4 Novartis Mycobacterium Tuberculosis Revenue in Global Market (2017-2022)
  7.15.5 Novartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Mycobacterium Tuberculosis Market Opportunities & Trends in Global Market
Table 2. Mycobacterium Tuberculosis Market Drivers in Global Market
Table 3. Mycobacterium Tuberculosis Market Restraints in Global Market
Table 4. Key Players of Mycobacterium Tuberculosis in Global Market
Table 5. Top Mycobacterium Tuberculosis Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Mycobacterium Tuberculosis Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Mycobacterium Tuberculosis Revenue Share by Companies, 2017-2022
Table 8. Global Companies Mycobacterium Tuberculosis Product Type
Table 9. List of Global Tier 1 Mycobacterium Tuberculosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mycobacterium Tuberculosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Mycobacterium Tuberculosis Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Mycobacterium Tuberculosis Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Mycobacterium Tuberculosis Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Mycobacterium Tuberculosis Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Mycobacterium Tuberculosis Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Mycobacterium Tuberculosis Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Mycobacterium Tuberculosis Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Mycobacterium Tuberculosis Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Mycobacterium Tuberculosis Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Mycobacterium Tuberculosis Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Mycobacterium Tuberculosis Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Mycobacterium Tuberculosis Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Mycobacterium Tuberculosis Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Mycobacterium Tuberculosis Revenue, (US$, Mn), 2023-2028
Table 30. Lupin Corporate Summary
Table 31. Lupin Mycobacterium Tuberculosis Product Offerings
Table 32. Lupin Mycobacterium Tuberculosis Revenue (US$, Mn), (2017-2022)
Table 33. Macleods Pharmaceuticals Corporate Summary
Table 34. Macleods Pharmaceuticals Mycobacterium Tuberculosis Product Offerings
Table 35. Macleods Pharmaceuticals Mycobacterium Tuberculosis Revenue (US$, Mn), (2017-2022)
Table 36. Otsuka Pharmaceutical Corporate Summary
Table 37. Otsuka Pharmaceutical Mycobacterium Tuberculosis Product Offerings
Table 38. Otsuka Pharmaceutical Mycobacterium Tuberculosis Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Mycobacterium Tuberculosis Product Offerings
Table 41. Johnson & Johnson Mycobacterium Tuberculosis Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Mycobacterium Tuberculosis Product Offerings
Table 44. Pfizer Mycobacterium Tuberculosis Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Mycobacterium Tuberculosis Product Offerings
Table 47. Novartis Mycobacterium Tuberculosis Revenue (US$, Mn), (2017-2022)
Table 48. Abbott Corporate Summary
Table 49. Abbott Mycobacterium Tuberculosis Product Offerings
Table 50. Abbott Mycobacterium Tuberculosis Revenue (US$, Mn), (2017-2022)
Table 51. AstraZeneca Corporate Summary
Table 52. AstraZeneca Mycobacterium Tuberculosis Product Offerings
Table 53. AstraZeneca Mycobacterium Tuberculosis Revenue (US$, Mn), (2017-2022)
Table 54. Bayer Corporate Summary
Table 55. Bayer Mycobacterium Tuberculosis Product Offerings
Table 56. Bayer Mycobacterium Tuberculosis Revenue (US$, Mn), (2017-2022)
Table 57. Merck Corporate Summary
Table 58. Merck Mycobacterium Tuberculosis Product Offerings
Table 59. Merck Mycobacterium Tuberculosis Revenue (US$, Mn), (2017-2022)
Table 60. Sanofi Corporate Summary
Table 61. Sanofi Mycobacterium Tuberculosis Product Offerings
Table 62. Sanofi Mycobacterium Tuberculosis Revenue (US$, Mn), (2017-2022)
Table 63. Thermo Fisher Scientific Corporate Summary
Table 64. Thermo Fisher Scientific Mycobacterium Tuberculosis Product Offerings
Table 65. Thermo Fisher Scientific Mycobacterium Tuberculosis Revenue (US$, Mn), (2017-2022)
Table 66. Danaher Corporate Summary
Table 67. Danaher Mycobacterium Tuberculosis Product Offerings
Table 68. Danaher Mycobacterium Tuberculosis Revenue (US$, Mn), (2017-2022)
Table 69. Roche Corporate Summary
Table 70. Roche Mycobacterium Tuberculosis Product Offerings
Table 71. Roche Mycobacterium Tuberculosis Revenue (US$, Mn), (2017-2022)
Table 72. Novartis Corporate Summary
Table 73. Novartis Mycobacterium Tuberculosis Product Offerings
Table 74. Novartis Mycobacterium Tuberculosis Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Mycobacterium Tuberculosis Segment by Type in 2021
Figure 2. Mycobacterium Tuberculosis Segment by Application in 2021
Figure 3. Global Mycobacterium Tuberculosis Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Mycobacterium Tuberculosis Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Mycobacterium Tuberculosis Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Mycobacterium Tuberculosis Revenue in 2021
Figure 8. By Type - Global Mycobacterium Tuberculosis Revenue Market Share, 2017-2028
Figure 9. By Application - Global Mycobacterium Tuberculosis Revenue Market Share, 2017-2028
Figure 10. By Region - Global Mycobacterium Tuberculosis Revenue Market Share, 2017-2028
Figure 11. By Country - North America Mycobacterium Tuberculosis Revenue Market Share, 2017-2028
Figure 12. US Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Mycobacterium Tuberculosis Revenue Market Share, 2017-2028
Figure 16. Germany Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 17. France Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Mycobacterium Tuberculosis Revenue Market Share, 2017-2028
Figure 24. China Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 28. India Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Mycobacterium Tuberculosis Revenue Market Share, 2017-2028
Figure 30. Brazil Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Mycobacterium Tuberculosis Revenue Market Share, 2017-2028
Figure 33. Turkey Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Mycobacterium Tuberculosis Revenue, (US$, Mn), 2017-2028
Figure 37. Lupin Mycobacterium Tuberculosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Macleods Pharmaceuticals Mycobacterium Tuberculosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Otsuka Pharmaceutical Mycobacterium Tuberculosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Mycobacterium Tuberculosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Mycobacterium Tuberculosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Mycobacterium Tuberculosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Abbott Mycobacterium Tuberculosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AstraZeneca Mycobacterium Tuberculosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bayer Mycobacterium Tuberculosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Merck Mycobacterium Tuberculosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sanofi Mycobacterium Tuberculosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Thermo Fisher Scientific Mycobacterium Tuberculosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Danaher Mycobacterium Tuberculosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Roche Mycobacterium Tuberculosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Novartis Mycobacterium Tuberculosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)